Nizax Activ (Ketoconazole)

Ketoconazole blocks the fungal enzyme lanosterol 14α‑demethylase, which is essential for producing ergosterol, a key component of fungal cell membranes. Without ergosterol, the membrane becomes defective, leading to fungal cell death and halting the spread of infection on the skin.

The specific dosage and frequency for Nizax Activ are determined by the prescribing healthcare professional based on the type and severity of the infection, the patient’s age, and other clinical factors. Patients should follow the prescriber’s instructions and the product label.

Safety data for topical ketoconazole during pregnancy and lactation are limited. Healthcare providers generally weigh the benefits against potential risks before prescribing. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss use with their clinician.

To request Nizax Activ, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with other topical antifungals such as clotrimazole or terbinafine, ketoconazole offers a broad spectrum against dermatophytes, yeasts, and some molds. Its azole class mechanism differs from allylamines like terbinafine, which target a separate step in ergosterol synthesis, providing clinicians with alternative options based on pathogen susceptibility and patient tolerance.

Nizax Activ should be stored at room temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed when not in use.

Apply a thin layer of the cream or ointment to the affected skin area once or twice daily, as directed by the prescriber. Gently rub it in until fully absorbed, and wash hands before and after application to avoid accidental contact with eyes or mucous membranes.

While generally well tolerated, serious risks include severe allergic reactions such as swelling, hives, or difficulty breathing, and rare but severe skin conditions like Stevens‑Johnson syndrome or toxic epidermal necrolysis. Immediate medical attention is required if any of these symptoms develop.

Individuals with known hypersensitivity to ketoconazole or any component of the formulation should avoid using Nizax Activ. It is also contraindicated on extensive broken skin, in patients with severe liver disease when systemic absorption is possible, and in those where a safer alternative is available.